drugset / Trial / NCT06055374
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and efficacy of a multiple SC dose of BxC-I17e in patients with moderate to severe atopic dermatitis (AD)
Timeline
- Start
- 2024-05-01
- Primary completion
- 2025-04-30
- Completion
- 2025-08-30
Outcome
Outcome not reported
Stopped: “This study was integrated into BRE-AD01-001 study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BxC-I17e | Other / unclassified | 50 ug | Subcutaneous |
| Subject | BxC-I17e | Other / unclassified | 100 ug | Subcutaneous |